Article info

Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial

Authors

  1. Correspondence to Dr Christopher Atkins; christopher.atkins{at}nnuh.nhs.uk
View Full Text

Citation

Atkins C, Jones A, Clark AB, et al
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial

Publication history

  • Received October 24, 2020
  • Revised March 8, 2021
  • Accepted April 16, 2021
  • First published May 21, 2021.
Online issue publication 
May 21, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.